Liwaiwai Liwaiwai
  • /
  • Artificial Intelligence
  • Machine Learning
  • Robotics
  • Engineering
    • Architecture
    • Design
    • Software
    • Hybrid Cloud
    • Data
  • Learning
  • About
  • /
  • Artificial Intelligence
  • Machine Learning
  • Robotics
  • Engineering
    • Architecture
    • Design
    • Software
    • Hybrid Cloud
    • Data
  • Learning
  • About
Liwaiwai Liwaiwai
  • /
  • Artificial Intelligence
  • Machine Learning
  • Robotics
  • Engineering
    • Architecture
    • Design
    • Software
    • Hybrid Cloud
    • Data
  • Learning
  • About
  • Artificial Intelligence
  • Data

IBM Releases Novel AI-Powered Technologies To Help Health And Research Community Accelerate The Discovery Of Medical Insights And Treatments For COVID-19

  • April 8, 2020
  • liwaiwai.com

IBM Research has been actively developing new cloud and AI-powered technologies that can help researchers across a variety of scientific disciplines accelerate the process of discovery. As the COVID-19 pandemic unfolds, we continue to ask how these technologies and our scientific knowledge can help in the global battle against coronavirus.

IBM makes available multiple novel, free resources to help healthcare researchers, doctors and scientists around the world accelerate COVID-19 drug discovery: from gathering insights, to applying the latest virus genomic information and identifying potential targets for treatments, to creating new drug molecule candidates.


Partner with liwaiwai.com
for your next big idea.
Let us know here.



From our partners:

CITI.IO :: Business. Institutions. Society. Global Political Economy.
CYBERPOGO.COM :: For the Arts, Sciences, and Technology.
DADAHACKS.COM :: Parenting For The Rest Of Us.
ZEDISTA.COM :: Entertainment. Sports. Culture. Escape.
TAKUMAKU.COM :: For The Hearth And Home.
ASTER.CLOUD :: From The Cloud And Beyond.
LIWAIWAI.COM :: Intelligence, Inside and Outside.
GLOBALCLOUDPLATFORMS.COM :: For The World's Computing Needs.
FIREGULAMAN.COM :: For The Fire In The Belly Of The Coder.
ASTERCASTER.COM :: Supra Astra. Beyond The Stars.
BARTDAY.COM :: Prosperity For Everyone.

Though some of the resources are still in exploratory stages, IBM is making them available to qualifying researchers at no charge to aid the international scientific investigation of COVID-19.

This announcement follows our recent leadership in launching the U.S. COVID-19 High Performance Computing Consortium, which is harnessing massive computing power in the effort to help confront the coronavirus.

Streamlining the Search for Information

Healthcare agencies and governments around the world have quickly amassed medical and other relevant data about the pandemic. And, there are already vast troves of medical research that could prove relevant to COVID-19. Yet, as with any large volume of disparate data sources, it is difficult to efficiently aggregate and analyze that data in ways that can yield scientific insights.

To help researchers access structured and unstructured data quickly, we are offering a cloud-based AI research resource that has been trained on a corpus of thousands of scientific papers contained in the COVID-19 Open Research Dataset (CORD-19), prepared by the White House and a coalition of research groups, and licensed databases from the DrugBank, Clinicaltrials.gov and GenBank. This tool uses our advanced AI and allows researchers to pose specific queries to the collections of papers and to extract critical COVID-19 knowledge quickly. Please note, access to this resource will be granted only to qualified researchers. To learn more and request access, please click here.

Read More  How ZSL Uses ML To Classify Gunshots To Protect Wildlife

Aiding the Hunt for Treatments

The traditional drug discovery pipeline relies on a library of compounds that are screened, improved, and tested to determine safety and efficacy. In dealing with new pathogens such as SARS-CoV-2, there is the potential to enhance the compound libraries with additional novel compounds. To help address this need, IBM Research has recently created a new, AI-generative framework which can rapidly identify novel peptides, proteins, drug candidates and materials.

We have applied this AI technology against three COVID-19 targets to identify 3,000 new small molecules as potential COVID-19 therapeutic candidates. IBM is releasing these molecules under an open license, and researchers can study them via a new interactive molecular explorer tool to understand their characteristics and relationship to COVID-19 and identify candidates that might have desirable properties to be further pursued in drug development.

To streamline efforts to identify new treatments for COVID-19, we are also making the IBM Functional Genomics Platform available for free for the duration of the pandemic. Built to discover the molecular features in viral and bacterial genomes, this cloud-based repository and research tool includes genes, proteins and other molecular targets from sequenced viral and bacterial organisms in one place with connections pre-computed to help accelerate discovery of molecular targets required for drug design, test development and treatment.

Select IBM collaborators from government agencies, academic institutions and other organizations already use this platform for bacterial genomic study. And now, those working on COVID-19 can request the IBM Functional Genomics Platform interface to explore the genomic features of the virus. Access to the IBM Functional Genomics Platform will be prioritized for those conducting COVID-19 research. To learn more and request access, please click here.

Read More  400% Increase In Demand For AI Email Security, As Cyber Threat Escalates

Drug and Disease Information

Clinicians and healthcare professionals on the frontlines of care will also have free access to hundreds of pieces of evidence-based, curated COVID-19 and infectious disease content from IBM Micromedex and EBSCO DynaMed. Using these two rich decision support solutions, users will have access to drug and disease information in a single and comprehensive search. Clinicians can also provide patients with consumer-friendly patient education handouts with relevant, actionable medical information. IBM Micromedex is one of the largest online reference databases for medication information and is used by more than 4,500 hospitals and health systems worldwide. EBSCO DynaMed provides peer-reviewed clinical content, including systematic literature reviews in 28 specialties for comprehensive disease topics, health conditions and abnormal findings, to highly focused topics on evaluation, differential diagnosis and management.

The scientific community is working hard to make important new discoveries relevant to the treatment of COVID-19, and we’re hopeful that releasing these novel tools will help accelerate this global effort. This work also outlines our long-term vision for the future of accelerated discovery, where multi-disciplinary scientists and clinicians work together to rapidly and effectively create next generation therapeutics, aided by novel AI-powered technologies.

Learn more about IBM’s response to COVID-19: IBM.com/COVID19.


For enquiries, product placements, sponsorships, and collaborations, connect with us at [email protected]. We'd love to hear from you!

Our humans need coffee too! Your support is highly appreciated, thank you!

liwaiwai.com

Related Topics
  • AI-Powered
  • Coronavirus
  • COVID-19
  • Drug
  • Health
  • High Performance Computing
  • IBM
  • Treatment
You May Also Like
View Post
  • Artificial Intelligence
  • Technology

AI For Impact: How Google Cloud Is Bringing AI To Accelerate Climate Action

  • December 4, 2023
ChatGPT
View Post
  • Artificial Intelligence
  • Engineering
  • Technology

Why Student Experiments With Generative AI Matter For Our Collective Learning

  • November 29, 2023
Code
View Post
  • Artificial Intelligence
  • Data
  • Engineering
  • Technology

Why We Can’t Leave AI To The Machines

  • November 28, 2023
Data center. Servers.
View Post
  • Data
  • Platforms
  • Software

Intel Granulate Optimizes Databricks Data Management Operations

  • November 27, 2023
Claude 2.1
View Post
  • Artificial Intelligence
  • Engineering
  • Tools

Introducing Claude 2.1

  • November 26, 2023
Microsoft. Windows
View Post
  • Artificial Intelligence
  • People
  • Technology

Ousted Sam Altman To Lead New Microsoft AI Team

  • November 21, 2023
View Post
  • Artificial Intelligence
  • Technology

Accelerating Climate Action With AI

  • November 20, 2023
Cloud
View Post
  • Artificial Intelligence
  • Machine Learning

DigitalOcean Currents Report Finds That Adoption Of AI/ML, And Investments In Cybersecurity And Multi-Cloud Strategies Are On The Rise At Small Businesses

  • November 20, 2023
A Field Guide To A.I.
Navigate the complexities of Artificial Intelligence and unlock new perspectives in this must-have guide.
Now available in print and ebook.

charity-water



Stay Connected!
LATEST
  • 1
    AI For Impact: How Google Cloud Is Bringing AI To Accelerate Climate Action
    • December 4, 2023
  • Birthday Cake 2
    How ChatGPT Altered Our World in Just One Year
    • December 1, 2023
  • 3
    Why Student Experiments With Generative AI Matter For Our Collective Learning
    • November 30, 2023
  • OpenAI 4
    Sam Altman Returns As CEO, OpenAI Has A New Initial Board
    • November 30, 2023
  • ChatGPT 5
    Why Student Experiments With Generative AI Matter For Our Collective Learning
    • November 29, 2023
  • Code 6
    Why We Can’t Leave AI To The Machines
    • November 28, 2023
  • Data center. Servers. 7
    Intel Granulate Optimizes Databricks Data Management Operations
    • November 27, 2023
  • Claude 2.1 8
    Introducing Claude 2.1
    • November 26, 2023
  • Ubuntu. Chiselled containers. 9
    Canonical Announces The General Availability Of Chiselled Ubuntu Containers
    • November 26, 2023
  • Cyber Monday Sale. Guzz. Ideals collection. 10
    Decode Workweek Style with guzz
    • November 24, 2023

about
About
Hello World!

We are liwaiwai.com. Created by programmers for programmers.

Our site aims to provide materials, guides, programming how-tos, and resources relating to artificial intelligence, machine learning and the likes.

We would like to hear from you.

If you have any questions, enquiries or would like to sponsor content, kindly reach out to us at:

[email protected]

Live long & prosper!
Most Popular
  • Oracle | Microsoft 1
    Oracle Cloud Infrastructure Utilized by Microsoft for Bing Conversational Search
    • November 7, 2023
  • Riyadh Air and IBM 2
    Riyadh Air And IBM Sign Collaboration Agreement To Establish Technology Foundation Of The Digitally Led Airline
    • November 6, 2023
  • Ingrasys 3
    Ingrasys Unveils Next-Gen AI And Cooling Solutions At Supercomputing 2023
    • November 15, 2023
  • Guzz. Black Friday Specials. 4
    Art Meets Algorithm In Our Exclusive Shirt Collection!
    • November 24, 2023
  • Presents. Gifts. 5
    25 Besties Bargain Bags Below $100 This Black Friday 2023
    • November 23, 2023
  • /
  • Artificial Intelligence
  • Explore
  • About
  • Contact Us

Input your search keywords and press Enter.